韩国做爰无遮A片床戏,第一财经电视直播,女人18毛片水真多,老头猛吸女大学奶头A片,借种灭门案完整观看国语

Avicenna
收藏雜志(zhi)
  • 數據(ju)庫收錄SCIE
  • 年發文(wen)量4

Avicenna

期(qi)刊中文名:阿維森納ISSN:2220-2749

該雜志國(guo)際簡稱:AVICENNA,是一(yi)本致力于(yu)發布--研究(jiu)(jiu)新成(cheng)(cheng)果(guo)的的專業學(xue)術期刊。主要(yao)發表刊登有(you)創見的學(xue)術論文文章、行業最新科研成(cheng)(cheng)果(guo),扼要(yao)報道階(jie)段(duan)性研究(jiu)(jiu)成(cheng)(cheng)果(guo)和重(zhong)要(yao)研究(jiu)(jiu)工作(zuo)的最新進(jin)展,選載對學(xue)科發展起指導作(zuo)用(yong)的綜述與專論,促進(jin)學(xue)術發展,為(wei)廣大讀者服(fu)務。該刊是一(yi)本國(guo)際優秀雜志,在國(guo)際上有(you)很高的學(xue)術影(ying)響力。

基本信息:
期(qi)刊簡稱:AVICENNA
是否OA:未開放
是否預警(jing):
Gold OA文章占比:0.00%
出版信息:
出(chu)版語言:English
評價信息:
JCR分(fen)區:Q1
影響因子:4.1
雜志(zhi)介(jie)紹 JCR分區 CiteScore 投(tou)稿經(jing)驗

雜志介紹

Avicenna雜志介紹

《Avicenna》是(shi)一本以(yi)English為主的(de)(de)(de)未開放(fang)獲取(qu)(qu)國際優秀期刊,中文名稱(cheng)阿維森(sen)納,本刊主要出版、報道領域(yu)的(de)(de)(de)研究動態以(yi)及在(zai)該(gai)領域(yu)取(qu)(qu)得的(de)(de)(de)各方(fang)面的(de)(de)(de)經驗和(he)科研成果(guo),介紹該(gai)領域(yu)有(you)關本專業的(de)(de)(de)最新進(jin)展(zhan),探討行業發展(zhan)的(de)(de)(de)思路和(he)方(fang)法,以(yi)促進(jin)學術信息交流,提高行業發展(zhan)。該(gai)刊已被國際權(quan)威數據庫SCIE收錄,為該(gai)領域(yu)相關學科的(de)(de)(de)發展(zhan)起到了良好的(de)(de)(de)推動作用(yong),也得到了本專業人員的(de)(de)(de)廣泛認可。該(gai)刊最新影響因(yin)子(zi)為4.1,

英文介紹

Avicenna雜志英文介紹

Avicenna is an influential academic journal. Widely covering research content in multiple fields such as medicine, philosophy, and science. In the field of medicine, in-depth exploration of the pathology, diagnosis, treatment methods, and medical history of various diseases, such as the study of rabies in medieval Persian literature, detailed the understanding of rabies at that time, including clinical manifestations, transmission routes, and treatment methods, and compared it with modern medical knowledge. In the field of philosophy, it involves the exploration of philosophical theories, the study of philosophical thoughts, and the research on Avicenna's own philosophical ideas and their role in the development of Eastern and Western philosophy. In the field of science, relevant scientific theories, experimental research, and other achievements will also be published.

This journal is committed to disseminating high-quality academic research results, promoting the intersection and integration of different disciplines, enhancing human understanding and recognition of fields such as medicine, philosophy, and science, and promoting academic progress and development. By publishing innovative and in-depth research papers, valuable references and inspirations can be provided to the academic community. Has a high reputation and influence in academic fields such as medicine, philosophy, and science. His published articles have been widely cited and referenced by numerous scholars, and have played a certain guiding role in the development direction of the discipline.

JCR分區(2023-2024年最新(xin)版)

Avicenna雜志 JCR分區信息

按JIF指標(biao)學科(ke)分區
學科:HEALTH POLICY & SERVICES
收錄子集:ESCI
分區:Q1
排名:8 / 118
百分位:

93.6%

按(an)JCI指標學科分(fen)區
學科:HEALTH POLICY & SERVICES
收錄子集:ESCI
分區:Q1
排名:12 / 119
百分位:

90.34%

JCR分區:JCR分(fen)區來(lai)自科(ke)睿(rui)唯安公司,JCR是(shi)一個(ge)獨特的(de)(de)(de)多學(xue)科(ke)期刊(kan)(kan)評價工(gong)具,為唯一提(ti)供基于引文(wen)數(shu)據的(de)(de)(de)統計信息的(de)(de)(de)期刊(kan)(kan)評價資源。每(mei)年發布的(de)(de)(de)JCR分(fen)區,設置了254個(ge)具體學(xue)科(ke)。JCR分(fen)區根據每(mei)個(ge)學(xue)科(ke)分(fen)類按照期刊(kan)(kan)當(dang)年的(de)(de)(de)影響因(yin)子(zi)高低將(jiang)期刊(kan)(kan)平(ping)均分(fen)為4個(ge)區,分(fen)別為Q1、Q2、Q3和Q4,各占25%。JCR分(fen)區中(zhong)期刊(kan)(kan)的(de)(de)(de)數(shu)量是(shi)均勻(yun)分(fen)為四個(ge)部分(fen)的(de)(de)(de)。

CiteScore 評價數據(2024年最新版)

Avicenna雜志CiteScore 評價數據

歷年影響因子和期刊自引率

投稿經驗

Avicenna雜志投稿經驗

該雜(za)志(zhi)是一(yi)(yi)本(ben)國際(ji)(ji)優秀(xiu)雜(za)志(zhi),在國際(ji)(ji)上有較高的學術(shu)影(ying)響(xiang)力,行業關注度很高,已被國際(ji)(ji)權威數據庫SCIE收錄,該雜(za)志(zhi)在綜(zong)合專(zhuan)業領域專(zhuan)業度認可很高,對稿(gao)(gao)(gao)件內容(rong)的創(chuang)新性和(he)學術(shu)性要求很高,作為一(yi)(yi)本(ben)國際(ji)(ji)優秀(xiu)雜(za)志(zhi),一(yi)(yi)般投(tou)(tou)(tou)稿(gao)(gao)(gao)過審(shen)時(shi)間都較長(chang),投(tou)(tou)(tou)稿(gao)(gao)(gao)過審(shen)時(shi)間平均 ,如(ru)(ru)果想投(tou)(tou)(tou)稿(gao)(gao)(gao)該刊要做好時(shi)間安排(pai)。版(ban)面費不(bu)祥。該雜(za)志(zhi)近(jin)兩(liang)年未被列入預警名(ming)單,建議您投(tou)(tou)(tou)稿(gao)(gao)(gao)。如(ru)(ru)您想了(le)解更多投(tou)(tou)(tou)稿(gao)(gao)(gao)政策(ce)及投(tou)(tou)(tou)稿(gao)(gao)(gao)方案,請咨詢(xun)客服。

免責聲明

若用戶需要(yao)出版服務(wu),請聯系出版商。